Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer

Published:2017-12 Issue:1 Volume:17 Page:
ISSN:1472-6882
Container-title:BMC Complementary and Alternative Medicine
language:en
Short-container-title:BMC Complement Altern Med

Author:

Thronicke Anja,Steele Megan L.,Grah Christian,Matthes Burkhard,Schad Friedemann

Funder

Iscador AG Arlesheim, Switzerland

ABNOBA GmbH, Pforzheim, Germany

Helixor GmbH, Rosenfeld, Germany

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12906-017-2045-0.pdf

Reference57 articles.

1. Kalathil SG, Thanavala Y. High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy. Cancer Immunol Immunother. 2016;65:813–9.

2. Tsirigotis P, Savani BN, Nagler A. Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies. Ann Med. 2016:1–12.

3. Ulmeanu R, Antohe I, Anisie E, Antoniu S. Nivolumab for advanced non-small cell lung cancer: an evaluation of a phase III study. Expert Rev Anticancer Ther. 2016;16:165–7.

4. Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627–39.

5. Brahmer J, Reckamp KL, Baas P, Crino L, Eberhardt WE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373:123–35.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with Advanced or Metastasised Non-Small-Cell Lung Cancer with Viscum album L. Therapy in Addition to PD-1/PD-L1 Blockade: A Real-World Data Study;Cancers;2024-04-22

2. Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours;Current Oncology Reports;2024-01-09

3. The Antioxidant Activity of Mistletoes (Viscum album and Other Species);Plants;2023-07-20

4. The Anti-Inflammatory Activity of Viscum album;Plants;2023-03-27

5. Phytotherapie in der Uroonkologie;Journal für Urologie und Urogynäkologie/Österreich;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3